ozempic vs tirzepatide Tirzepatide vs Semaglutide for Weight

10.1016/j.molmet.2019.09.010 Mol

As its full safety profile remains under investigation, the following reflects current available data and known class effects: Gastrointestinal symptoms are the most common: nausea, vomiting, diarrhoea, and constipation, particularly during dose escalation

That growth is driven almost entirely by the success of prescription GLP-1 drugs and the desire of consumers to access similar benefits without injections, prescriptions, or high costs

Physical examination and appropriate laboratory investigations are important components of evaluation

It becomes drier due to impaired barrier function and decreased production of essential oil like sebum